BIOARRAY is playing a role in the fight against breast cancer by bringing patients new molecular tests using genome-wide gene expression technology. Our lead diagnostic will personalize breast cancer treatment by providing a patient and her doctor with the information needed to choose between multiple approved chemotherapy regimens. We are an early-stage biotechnology company based in Boston and incorporated in 2009. BIOARRAY is a Silver Winner at MassChallenge 2011.